Fundraising FoxOnconetix
NASDAQ: ONCOCincinnati, US · Founded 2018 · Delaware corporation
Find your way into Onconetix
Sign up to see every warm intro you have to Onconetix
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Onconetix team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Onconetix is a commercial-stage biotechnology company that researches, develops, and commercializes proprietary therapeutics, diagnostics, and services in oncology. It serves clinicians and patients, with a product line that includes the Proclarix diagnostic.
Founders & leadership
KF
Karina FedaszExecutive
RS
Ralph SchiessExecutive
JH
Joseph HernandezNamed on SEC filing
Board
TR
Timothy RamdeenBoard director
AS
Ajit SinghBoard director
ST
Simon TarshBoard director
TM
Thomas MeierBoard director
JS
James SapirsteinBoard director
Reported raises · per SEC filings
Form D private placements$22M disclosed across 3 rounds · 2019–2025
▶$13MraisedOct 2025 · 11 investors · BiotechnologyRule 506(b)
▶$13MraisedOct 2025 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Simon TarshDirector
- Karina FedaszExecutive Officer
- Andrew OakleyDirector
- Timothy RamdeenDirector
- Thomas MeierDirector
- Offering amount
- $13M
- Amount sold
- $13M
- Minimum investment
- $208.8K
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedOct 2024 · 5 investors · BiotechnologyRule 506(b)
▶$2MraisedOct 2024 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Simon TarshDirector
- Karina FedaszExecutive Officer
- Thomas MeierDirector
- Timothy RamdeenDirector
- James SapirsteinDirector
- Ajit SinghDirector
- Ralph SchiessExecutive Officer
- Offering amount
- $2M
- Amount sold
- $2M
- Sales commissions
- $160K
- Placement agents
- Finalis Securities, LLC
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7MraisedJul 2019 · 5 investors · BiotechnologyRule 506(b)
▶$7MraisedJul 2019 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph HernandezExecutive Officer
- Offering amount
- $7M
- Amount sold
- $7M
- Proceeds to insiders
- $300K
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
Simply Wall StSimply Wall St is an investment platform that provides financial data visualization and analysis tools for individual investors. The platform serves long-term investors globally by simplifying complex market information into visual and narrative formats to make stock investing more accessible.
PerplexityAn AI-powered answer engine providing accurate, trusted, and real-time answers to questions.
NasdaqNasdaq operates a technology infrastructure platform for financial markets across three business segments: Capital Access Platforms (which includes listing services, indices, and analytics tools), Financial Technology (comprising compliance, regulatory, and capital markets software), and Market Services (equities and derivatives trading operations). The company serves financial institutions, listed companies, investment managers, and regulatory agencies globally.
Companies working in the same space as Onconetix.
In the news
Frequently asked questions
- What does Onconetix do?
- Onconetix is a commercial-stage biotechnology company that researches, develops, and commercializes proprietary therapeutics, diagnostics, and services in oncology. It serves clinicians and patients, with a product line that includes the Proclarix diagnostic.
- How much funding has Onconetix raised?
- Onconetix has disclosed $22M raised across 3 rounds.
- Where is Onconetix headquartered?
- Onconetix is headquartered in Cincinnati, US.